Functionalized 3-benzylidene-indolin-2-ones: inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity.

Functionalized benzylidene-indolin-2-ones are widely associated with antiproliferative activity. The scaffold is not normally associated with chemoprevention in spite of the presence of a nitrogen-linked Michael acceptor moiety that may predispose members to induction of NQO1, a widely used biomarker of chemopreventive potential. To investigate this possibility, we have synthesized and evaluated a series of functionalized 3-benzylidene-indolin-2-ones for induction of NQO1 in murine Hepa1c1c7 cells as well as antiproliferative activity against two human cancer cell lines (MCF-7, HCT116). The benzylideneindolinones were found to be good inducers of NQO1 activity, with 85% of test compounds able to increase basal NQO1 activity by more than twofold at concentrations of 10 microM. By contrast, fewer compounds (11%) tested at the same concentration were able to reduce cell viability by more than 50%. Structure activity relationships showed that the nitrogen linked Michael acceptor moiety was an essential requirement for both activities. This common feature notwithstanding, substitution of the 3-benzylidene-indolin-2-one core structure affected NQO1 induction and antiproliferative activities in dissimilar ways, underscoring different structural requirements for these two activities. Nonetheless, promising compounds (10, 42, 45-48) were identified that combine selective induction of NQO1 with potent antiproliferative activity. A potential advantage of such agents would be the ability to provide added protection to normal cells by the up-regulation of NQO1 and other phase II enzymes while simultaneously targeting neoplastic cells.

[1]  J. Pezzuto,et al.  Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. , 1995, Carcinogenesis.

[2]  J. Pezzuto,et al.  Characterization of Natural Product Chemopreventive Agents , 2005 .

[3]  L. Landi,et al.  DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function. , 1997, Free radical biology & medicine.

[4]  D. Liebler,et al.  The Reduction of α-Tocopherolquinone by Human NAD(P)H:Quinone Oxidoreductase: The Role of α-Tocopherolhydroquinone as a Cellular Antioxidant , 1997 .

[5]  A. Jaiswal,et al.  NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53. , 2007, Cancer research.

[6]  Eiichi Akaho,et al.  Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies. , 2005, Farmaco.

[7]  A. Kong,et al.  Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. , 2005, Trends in pharmacological sciences.

[8]  Xifu Liang,et al.  Indolin-2-ones with high in vivo efficacy in a model for multiple sclerosis. , 2005, Journal of medicinal chemistry.

[9]  Paul Talalay,et al.  Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Kunkel,et al.  Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1. , 2006, Journal of medicinal chemistry.

[11]  P. Nioi,et al.  Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. , 2004, Mutation research.

[12]  M. Paquet,et al.  Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis. , 2005, Cancer research.

[13]  Bharat B. Aggarwal,et al.  Genetic Deletion of NAD(P)H:Quinone Oxidoreductase 1 Abrogates Activation of Nuclear Factor-κB, IκBα Kinase, c-Jun N-terminal Kinase, Akt, p38, and p44/42 Mitogen-activated Protein Kinases and Potentiates Apoptosis* , 2006, Journal of Biological Chemistry.

[14]  Gerald Batist,et al.  Transcriptional Regulation of NF-E2 p45-related Factor (NRF2) Expression by the Aryl Hydrocarbon Receptor-Xenobiotic Response Element Signaling Pathway , 2005, Journal of Biological Chemistry.

[15]  A. Dinkova-Kostova,et al.  Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers. , 1998, Journal of medicinal chemistry.

[16]  C. Wolf,et al.  The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. , 2001, Cancer research.

[17]  D. Brauze Comparison of the induction of a 4S β-naphthoflavone-binding protein, cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in β-naphthoflavone-treated rats , 2004 .

[18]  U. Burger,et al.  Cyclization Studies with N-Mannich bases of 2-substituted indoles , 1989 .

[19]  A. Dinkova-Kostova,et al.  Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates. , 2004, Methods in enzymology.

[20]  G. Mcmahon,et al.  Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. , 1998, Journal of medicinal chemistry.

[21]  A. Santamaria,et al.  Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. , 1988, Analytical biochemistry.

[22]  P. Righetti,et al.  (Z)- and (E)-Arylidene-1,3-dihydroindol-2-ones: configuration, conformation, and infrared carbonyl stretching frequencies , 1984 .

[23]  C. Papageorgiou,et al.  Acid‐Catalyzed Rearrangements for a Diastereoselective Entry into a New Fused Hexacyclic Heterocycle: (5RS,7aRS,12RS,14aRS,)‐4,5,7a,11,12,14,14a‐octahydro‐5,12‐dimethyl‐diindolo [1,7‐bc: 1′,7′‐gh][2,6] naphthyridine , 1988 .

[24]  R. Cole,et al.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Ashida,et al.  Antagonistic and agonistic effects of indigoids on the transformation of an aryl hydrocarbon receptor. , 2008, Archives of biochemistry and biophysics.

[26]  A. Andreani,et al.  Synthesis and cardiotonic activity of 2-indolinones , 1990 .

[27]  W. Baer-Dubowska,et al.  The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver. , 2006, Toxicology letters.

[28]  R. Barouki,et al.  Regulation of NAD(P)H:quinone oxidoreductase 1 gene expression by CYP1A1 activity. , 2004, Molecular pharmacology.

[29]  Michael O. Kelleher,et al.  The cancer chemopreventive actions of phytochemicals derived from glucosinolates , 2008, European journal of nutrition.

[30]  R. Mayer,et al.  Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. , 1974, Drug metabolism and disposition: the biological fate of chemicals.

[31]  D A Scudiero,et al.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.

[32]  J. Hayes,et al.  Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. , 2000, Cancer research.

[33]  P. N. Craig,et al.  Interdependence between physical parameters and selection of substituent groups for correlation studies. , 1971, Journal of medicinal chemistry.

[34]  Y. Surh,et al.  Cancer chemoprevention with dietary phytochemicals , 2003, Nature Reviews Cancer.

[35]  P. O'Brien,et al.  Coenzyme Q cytoprotective mechanisms. , 2004, Methods in enzymology.

[36]  G L Snyder,et al.  Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? , 2001, The Journal of biological chemistry.

[37]  Y. Kan,et al.  Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduc , 2004, The Biochemical journal.

[38]  D. Roop,et al.  NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. , 2000, Cancer research.

[39]  K. Bock,et al.  Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention. , 2006, Biochemical pharmacology.

[40]  P. Talalay,et al.  Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. , 1988, Cancer research.

[41]  A. Fornace,et al.  Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. , 1990, Environmental health perspectives.

[42]  Ping Chen,et al.  Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416. , 2006, Bioorganic & medicinal chemistry.

[43]  D. Ross,et al.  NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. , 2004, Methods in enzymology.

[44]  M. Massiah,et al.  Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  K. Bock,et al.  Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. , 2007, Biochemical pharmacology.

[46]  J. Pezzuto,et al.  Quinone reductase induction as a biomarker for cancer chemoprevention. , 2006, Journal of natural products.

[47]  Shigetoshi Takahashi,et al.  Rhodium-catalyzed carbonylation of 2-alkynylaniline: Syntheses of 1,3-dihydroindol-2-ones , 1995 .

[48]  A. Jaiswal,et al.  Antioxidant response element. , 1994, Biochemical pharmacology.

[49]  Y. Fujii‐Kuriyama,et al.  Ah receptor, a novel ligand-activated transcription factor. , 1997, Journal of biochemistry.